2004
Characterizing ectopic pregnancies that rupture despite treatment with methotrexate
Dudley P, Heard M, Sangi-Haghpeykar H, Carson S, Buster J. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertility And Sterility 2004, 82: 1374-1378. PMID: 15533363, DOI: 10.1016/j.fertnstert.2004.03.066.Peer-Reviewed Original ResearchConceptsTubal ruptureEctopic pregnancyRisk factorsHCG valuesHuman chorionic gonadotropin valuesRetrospective case-control analysisIndependent risk factorUrban medical centerCase-control analysisConcentrations of hCGEctopic gestationMTX administrationIndependent predictorsSurgical interventionGonadotropin valuesHCG concentrationsMAIN OUTCOMEMedical CenterMethotrexateImplantation sitesPregnancyTubal isthmusPatientsPredictive variablesTreatment
2000
Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series
Casson P, Lindsay M, Pisarska M, Carson S, Buster J. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction 2000, 15: 2129-2132. PMID: 11006185, DOI: 10.1093/humrep/15.10.2129.Peer-Reviewed Original ResearchConceptsHuman chorionic gonadotrophinOvarian stimulationDHEA treatmentPoor respondersPoor responseInsulin-like growth factor-1 effectsGrowth hormonePg/Healthy non-smoking womenDay 3 FSHOvarian stimulation responseOvarian stimulation cyclesNon-smoking womenPeak oestradiol concentrationsGonadotrophin doseDehydroepiandrosterone administrationGonadotrophin administrationOvarian responseCase seriesTwin pregnanciesMIU/Intrauterine inseminationOestradiol concentrationsFollicular maturityChorionic gonadotrophin
1994
Basal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)-intrauterine insemination (IUI) therapy
Burwinkel T, Buster J, Scoggan J, Carson S. Basal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)-intrauterine insemination (IUI) therapy. Journal Of Assisted Reproduction And Genetics 1994, 11: 24-27. PMID: 7949831, DOI: 10.1007/bf02213693.Peer-Reviewed Original ResearchConceptsBasal FSHPeak estradiolAnovulatory groupOvarian hyperstimulationOvarian responsivenessBasal follicleOvulatory groupRetrospective chart reviewIntrauterine insemination (IUI) therapyAnovulatory patientsMore ampoulesOvulatory patientsChart reviewPatient ageInfertility patientsMIU/Intrauterine inseminationFollicle numberPregnancy occurrenceTreatment outcomesClinical dataCycle dayHormone measurementsFSHTreatment cycles
1991
Superovulation fails to increase human blastocyst yield after uterine lavage
Carson S, Smith A, Scoggan J, Buster J. Superovulation fails to increase human blastocyst yield after uterine lavage. Prenatal Diagnosis 1991, 11: 513-522. PMID: 1766927, DOI: 10.1002/pd.1970110806.Peer-Reviewed Original ResearchConceptsUterine lavageFertile womenHuman chorionic gonadotropin administrationBlastocyst recoveryChorionic gonadotropin administrationBlastocyst yieldGonadotropin administrationOvulation inductionTotal fluid volumeLavage techniqueLavagePreimplantation genetic diagnosisFluid volumeInsemination timingWomenGenetic diagnosisDiagnosisDonor inseminationSuperovulationPreimplantation diagnosisEmbryo collectionDaysInseminationRegimensComplicationsMethotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall T, Ling F, Gray L, Carson S, Buster J. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstetrics And Gynecology 1991, 77: 749-53. PMID: 2014090.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAlgorithmsChorionic GonadotropinDrug Administration ScheduleDrug Therapy, CombinationFemaleHumansLeucovorinMethotrexatePregnancyPregnancy, TubalConceptsUnruptured ectopic pregnancyEctopic pregnancyConservative surgical proceduresHCG titerPatient nosPrimary therapySurgical proceduresSide effectsPrevious ectopic pregnancyRecurrent ectopic pregnancyIdentifiable risk factorsOngoing clinical trialsCardiac activityTubal pregnancyPersistent diseaseFourth doseMedical therapyMethotrexate treatmentOutpatient protocolInvolved sideTubal patencyRisk factorsClinical trialsPregnancyPatientsLow human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies
Carson S, Stovall T, Ling F, Buster J. Low human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies. Fertility And Sterility 1991, 55: 629-630. PMID: 2001763, DOI: 10.1016/s0015-0282(16)54198-3.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, SpontaneousBiomarkersChorionic GonadotropinFemaleHumansPlacental LactogenPregnancyPregnancy, EctopicProgesteroneProspective Studies
1989
Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy
Carson S, Stovall T, Umstot E, Andersen R, Ling F, Buster J. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy. Fertility And Sterility 1989, 51: 593-597. PMID: 2466704, DOI: 10.1016/s0015-0282(16)60605-2.Peer-Reviewed Original ResearchConceptsHuman chorionic somatomammotropinEctopic pregnancyBeta-human chorionic gonadotropinEctopic pregnancy ruptureChorionic somatomammotropinSurgical therapyBeta-hCGMethotrexate chemotherapyMethotrexate treatmentMedical managementTrophoblastic activityHCS levelsChorionic gonadotropinAuthors' seriesPregnancyPatientsSensitive indicatorRuptureChemotherapyGonadotropinMethotrexateProgesteroneTherapyWomen